Cargando…
Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765691/ https://www.ncbi.nlm.nih.gov/pubmed/31512163 http://dx.doi.org/10.1007/s40261-019-00852-y |
| _version_ | 1783454554651623424 |
|---|---|
| author | Lyseng-Williamson, Katherine A. |
| author_facet | Lyseng-Williamson, Katherine A. |
| author_sort | Lyseng-Williamson, Katherine A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6765691 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67656912019-10-09 Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features Lyseng-Williamson, Katherine A. Clin Drug Investig Correction Springer International Publishing 2019-09-12 2019 /pmc/articles/PMC6765691/ /pubmed/31512163 http://dx.doi.org/10.1007/s40261-019-00852-y Text en © Springer Nature 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. |
| spellingShingle | Correction Lyseng-Williamson, Katherine A. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title | Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title_full | Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title_fullStr | Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title_full_unstemmed | Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title_short | Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features |
| title_sort | correction to: glucagon-like peptide-1 receptor agonists in type 2 diabetes: their use and differential features |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6765691/ https://www.ncbi.nlm.nih.gov/pubmed/31512163 http://dx.doi.org/10.1007/s40261-019-00852-y |
| work_keys_str_mv | AT lysengwilliamsonkatherinea correctiontoglucagonlikepeptide1receptoragonistsintype2diabetestheiruseanddifferentialfeatures |